Orbimed Advisors LLC Seagen Inc. Call Options Transaction History

Orbimed Advisors LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $9.58 Million - $10.8 Million	50,000 New	50,000 $10.6 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $3.38 Million - $4.5 Million	-25,000 Reduced 50.0%	25,000 $3.42 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $5.44 Million - $8.97 Million	50,000 New	50,000 $8.85 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.